News Agency News Aggregator Journalist/Editor Broking House Others
Sun Pharma Launches SEZABY™ in the U.S. for Treatment of Neonatal Seizures #SunPharmaceuticalIndustries #INE044A01036 #SEZABY #PhenobarbitalSodium #US #Launch #NeonatalSeizures
#CNBCTV18Market | Sun Pharma recovers, stock more than 1% off lows
#JustIn | Sun Pharma launches Sezaby Phenobarbital Sodium in the US -The company launches Sezaby for the treatment of Neonatal Seizures #SunPharma #US
#JustIn | Sun Pharma launches SEZABY in the US used to treat Neonatal Seizures
SUNPHARMA - Announcement under Regulation 30 (LODR)-Press Release / Media Release
#SUNPHARMA in focus as TARO reports weak Q3FY23 Net sales at $139.2 million vs $138.98m Operating income of $1.3Mln vs $37 Mln Margins 1% vs 27% Net income $7.3Mln vs $26.3Mln down 72% Continued price pressure in US generic biz Op inc lower due to price erosion
Macquarie on SUN Pharma O-P, TP Rs 1275 Taro 3Q : All-round beat; rev/EBITDA/PAT beat est. by 11%, 38%, & 4%, respectively Co mentioned continued price pressures in US market B/S strong with total cash & cash equivalents of $1.2bn as of Dec 2022 @ekta_batra @CNBCTV18News
#CNBCTV18Market | Macquarie gives outperform rating on Sun Pharma following beat Q3 earnings from Taro Pharma
Torrent Pharma : 03/02/2023 Vaibhav Global : 03/02/2023 Vedanta : 04/02/2023 SRF Ltd. 07/02/2023 Coal India Ltd. : 08/02/2023 Power Grid : 08/02/2023 Sun Pharma : 08/02/2023 MOIL : 08/02/2023 Gillette India : 09/02/2023 Clean Science : 10/02/2023
Sun pharma shorts closed
#SUNPHARMA leads #NiftyPharma components in 36-month performance.
Sell torrent pharma 1608 stop. Sell wipro n Sun pharma
#LMMarketSnippets 24 Jan 2023 - #NiftyPharma index up 1% led by Sun Pharma Biocon and Lupin. Disclaimer:
#SUNPHARMA within 5% of 50-day moving average. #BuyingOpportunity #TradingOpportunity ?